How Azenta’s Dual Russell 2000 Defensive Index Addition Will Impact Azenta (AZTA) Investors
Azenta, Inc. (NasdaqGS: AZTA) was recently added to both the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, which could increase its visibility among institutional investors. While this inclusion may boost liquidity, it does not fundamentally alter the near-term earnings pressure or the risk of strain on margins due to higher spending and soft spots in core services. Additionally, despite a fair value estimate aligning with its current price and projected revenue growth, concerns about margin pressure and execution remain among analysts.
Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This investigation follows a significant drop in Azenta's stock price after the company reported disappointing Q2 2026 financial results, missing EPS and revenue estimates, announcing a goodwill impairment, and reducing its 2026 outlook. The firm is encouraging affected shareholders to contact them to learn more about the investigation.
Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ:AZTA) following a significant drop in its stock price. The investigation comes after Azenta reported disappointing Q2 2026 financial results, including missed consensus estimates for EPS and revenue, a $149 million goodwill impairment, and a reduced 2026 outlook. Shareholders who purchased Azenta securities are encouraged to contact the firm to learn more about the investigation.
AZTA - Azenta Inc Options
This article provides detailed financial data and performance metrics for Azenta Inc. (AZTA), including its stock performance, market capitalization, earnings, sales figures, and various ratios. It also lists insider and institutional ownership, analyst recommendations, and key volatility indicators.
Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)?
This article evaluates Azenta, Inc. (NASDAQ:AZTA) to determine if it presents a current investment opportunity. Given the limited content, a more detailed analysis is not possible.
AZTA SEC Filings - Azenta Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Azenta Inc. (AZTA) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms. Recent filings detail insider transaction amendments, sales related to RSU vesting, and a Q3 2025 earnings report. StockTitan also offers AI-generated summaries, impact scoring, and sentiment analysis for each filing.
Azenta (NASDAQ:AZTA) Shift Puts Its Defensive Story In Focus
Azenta (NASDAQ:AZTA) is gaining attention after its inclusion in defensive Russell benchmarks, which gives the company a clearer market identity. The company, which provides sample management, storage, and multiomics services for life sciences customers, will need to focus on service growth, margin improvement, demand recovery, and execution discipline to maintain future investor interest. The main risk to Azenta is softer demand and margin pressure.
ETFs Investing in Azenta, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Azenta, Inc. It provides a detailed table including each fund's market value, weight of Azenta stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV total return. The information aims to help investors identify ETFs with exposure to Azenta, Inc. while highlighting the benefits of diversified investing through ETFs.
Does Azenta (AZTA) Joining Defensive Russell Indexes Recast Its Role as a Value-Oriented Compounder?
Azenta, Inc. (AZTA) has been included in the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, which may boost its visibility and liquidity. However, this index inclusion does not change the fundamental investment narrative, which remains focused on the execution of its life sciences services growth plan and addressing risks like order softness and margin pressure. Investors should consider the potential for growth in its multiomics and sample management offerings against ongoing financial challenges, including recent goodwill impairments and net losses.
Price to sales forward of Azenta, Inc. – NASDAQ:AZTA
This page provides financial information for Azenta, Inc. (NASDAQ: AZTA), specifically focusing on its price to sales forward metric. It also lists various sections available on TradingView related to the company, including financials, news, technicals, and forecasts.
Price to earnings forward of Azenta, Inc. – TRADEGATE:BA3
This article briefly mentions the "Price to earnings forward of Azenta, Inc. – TRADEGATE:BA3" and indicates that the market is closed with no trades. It appears to be a stub or a section from a financial data platform like TradingView, lacking detailed financial analysis or figures.
Enterprise value to revenue forward of Azenta, Inc. – NASDAQ:AZTA
This article provides a financial snapshot focusing on the enterprise value to revenue forward for Azenta, Inc. (NASDAQ: AZTA). It appears to be a stub or an incomplete data point from a financial data platform, indicating the metric for the company. The content includes minimal financial details but highlights the company's ticker and market.
Enterprise value to EBITDA forward of Azenta, Inc. – TRADEGATE:BA3
The article provides the Enterprise Value to EBITDA forward for Azenta, Inc. (TRADEGATE:BA3). It indicates that the market was closed with no trades at the time of publication. The content also lists various financial tools and community features offered by TradingView.
Azenta, Inc. Actuals & Estimates (NASDAQ:AZTA)
This article provides an in-depth financial overview of Azenta, Inc. (NASDAQ:AZTA), covering its stock performance, analyst forecasts, historical highs and lows, volatility, market capitalization, and upcoming earnings reports. It details recent earnings surprises, revenue figures, net income, and EBITDA, along with employee numbers and advice on how to trade its stock.
Azenta Inc Unsponsored Brazilian Depositary Receipt Repr 0.083333333 Sh Actuals & Estimates (BMFBOVESPA:A2ZT34) — TradingView
This TradingView page provides an overview of Azenta Inc.'s unsponsored Brazilian Depositary Receipt (A2ZT34) on the BMFBOVESPA. It offers access to financial actuals and analyst estimates, including income statement, balance sheet, and cash flow data, allowing users to compare results and visualize trends. The platform also includes a disclaimer that this information is not investment advice and encourages users to conduct their own research.
AZTA Forecast — Price Target — Prediction for 2027
This article provides a detailed forecast and analysis for Azenta, Inc. (AZTA) stock, including analyst price targets, past performance, and future earnings estimates. It covers various financial metrics, such as stock price, market capitalization, EBITDA, and revenue, along with frequently asked questions about investing in AZTA. The information is presented by TradingView, emphasizing the need for individual research before making investment decisions.
The Bull Case For Azenta (AZTA) Could Change Following Profitability Surge And Bullish Signals – Learn Why
Azenta (AZTA) has shown improved financial performance with increased net profit and strong operational efficiency, which could shift its investment narrative. The company's recent profitability surge and bullish technical indicators suggest strengthening investor optimism despite potential challenges like slower capital spending. The appointment of Trey Martin as President of Multiomics is expected to aid in improving operational execution and driving growth.
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates
The article provides an earnings forecast for Azenta Inc (AZTA), noting its current earnings forecast score is 7.43, ranking 291 out of 388 in its industry. Analysts have given an average price target of $41.00, with a "Buy" trend recommendation based on 7 analysts. The expected revenue for the next quarter is $149.29 million, and the EPS for the next quarter is projected at $0.10.
Azenta Inc (AZTA) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Azenta Inc (AZTA), listing its major shareholders and their proportional holdings, current as of May 13th. It also provides insights into institutional shareholding trends over several quarters, showing changes in the number of institutions and shares held. Additionally, the article highlights the company's inclusion in various related ETFs, indicating its presence in different investment portfolios.
The Bull Case For Azenta (AZTA) Could Change Following Lowered 2026 Outlook And Multiomics Overhaul – Learn Why
Azenta (AZTA) experienced a 3% organic revenue decline in Q2 2026, leading to a lowered full-year guidance for organic revenue and compressed adjusted EBITDA margins. The company is undergoing leadership changes, including a new President for Multiomics, and is integrating UK Biocentre to address these operational challenges and soften North American demand. Despite a projected 15% upside to its current price based on fair value estimates, the revised outlook and execution issues warrant a re-evaluation of the previously optimistic investment narrative.
Azenta names Trey Martin president of Multiomics business By Investing.com
Azenta, Inc. has appointed Trey Martin as President of its Multiomics business, effective April 6, 2026, to lead the next phase of its multiomics strategy. Martin brings over 30 years of leadership experience in life sciences and previously served as CEO of Maravai Life Sciences and held senior roles at Danaher Corporation. The appointment follows Azenta's Investor Day plans to scale global synthesis capabilities and drive growth.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (AZTA) on behalf of investors. This investigation follows Azenta's Q2 fiscal 2026 results, which fell short of expectations, revealing "execution gaps" and a "more cautious demand environment," a $149 million goodwill impairment, and a reduced fiscal 2026 outlook. Following this news, Azenta's stock price dropped over 25%.
How Azenta Inc. (AZTA) Affects Rotational Strategy Timing
This article analyzes Azenta Inc. (AZTA) using AI models to provide trading strategies and a multi-timeframe signal analysis. It highlights strong near and mid-term sentiment but a weak long-term outlook for AZTA, presenting specific entry, target, and stop-loss zones for position, momentum breakout, and risk hedging strategies. The analysis also details support and resistance signals across different time horizons.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ:AZTA) following a significant drop in its stock price. This comes after Azenta reported missing second-quarter consensus estimates, announced a $149 million goodwill impairment, and reduced its 2026 financial outlook due to execution shortfalls and a cautious demand environment. The firm is encouraging shareholders to connect to assist with the investigation.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (AZTA) after the company missed Q2 2026 earnings estimates, reported a significant goodwill impairment, and lowered its 2026 outlook. Following this news, Azenta's stock price dropped by over 25%. The firm is encouraging shareholders to join the investigation.
Azenta, Inc. (AZTA) Securities Fraud Investigation - Levi & Korsinsky
Levi & Korsinsky has announced a securities fraud investigation into Azenta, Inc. (AZTA) after the company slashed its FY 2026 guidance in May 2026, just three months after reaffirming strong organic revenue growth and margin expansion targets. The revision followed a $149 million goodwill impairment and a significant net loss, prompting questions about management's awareness of changing conditions. Shareholders who suffered losses are encouraged to contact Levi & Korsinsky for a free evaluation of their legal rights.
Azenta, Inc. (AZTA) Securities Fraud Investigation - Levi & Korsinsky
Levi & Korsinsky, LLP has launched a securities fraud investigation into Azenta, Inc. (AZTA) following a significant drop in its stock value. This comes after Azenta reaffirmed strong organic revenue growth and margin expansion guidance in February 2026, only to cut these targets three months later and report a $149 million goodwill impairment and a net loss. The investigation focuses on whether the company made misleading statements to investors regarding its financial outlook.
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is continuing its investigation into Azenta, Inc. (AZTA) for potential violations of federal securities laws after the company missed Q2 2026 financial estimates, reported a significant goodwill impairment, and reduced its 2026 outlook. Following this news, Azenta's stock price dropped by 25.3%, causing losses for investors. Shareholders who lost money are encouraged to contact the law firm to learn more about pursuing a claim.
Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Azenta, Inc. (NASDAQ:AZTA) shareholders after the company missed Q2 2026 EPS and revenue estimates, reported a $149 million goodwill impairment, and reduced its 2026 outlook. Following this news, Azenta's stock price dropped significantly. The law firm is encouraging affected investors to contact them to learn more about the investigation.
Investors in Azenta, Inc. (AZTA) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
Levi & Korsinsky has launched an investigation into Azenta, Inc. (AZTA) for potential securities fraud. This follows a significant goodwill impairment charge and reduced full-year guidance on May 5, 2026, which contradicted the CEO's positive outlook and reaffirmed guidance given just ninety days earlier on February 4, 2026. Shareholders who suffered losses are encouraged to contact Levi & Korsinsky for potential recovery under federal securities laws.
Bronstein, Gewirtz & Grossman, LLC Encourages Azenta, Inc. (AZTA) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Azenta, Inc. (NASDAQ: AZTA) securities. This follows Azenta's announcement of second-quarter 2026 financial results, which missed EPS and revenue estimates, included a $149 million goodwill impairment, and led to a reduced 2026 outlook and a significant drop in stock price. The firm is encouraging stockholders to assist in their investigation.
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast
Azenta Inc. has announced its fiscal 2025 second-quarter earnings conference call and webcast. Quantisnow Plus members received an alert about this announcement shortly after its publication. The company provides real-time market data to retail investors.
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
The Law Offices of Howard G. Smith are investigating Azenta, Inc. (AZTA) on behalf of investors who suffered losses, looking into possible violations of federal securities laws. This investigation follows Azenta's announcement of disappointing Q2 2026 financial results, missing EPS and revenue estimates, reporting a $149 million goodwill impairment, and reducing its 2026 organic revenue and adjusted EBITDA margin outlook. Consequently, Azenta's stock price dropped by 25.3% on May 6, 2026, harming investors.
A Look at Azenta Inc (AZTA) After 3.2% Gain -- GF Value $63.29 v
Azenta Inc. (AZTA) shares rose 3.2% today, but the stock is down significantly year-to-date and over the past year. GuruFocus classified AZTA as "undervalued" with a GF Value™ of $63.29 against a current price of $20.18, yet it carries a "Possible Value Trap" warning due to its high P/E ratio compared to historical levels. Despite insider buying, investors are cautioned to perform further analysis before investing.
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues
The Law Offices of Frank R. Cruz is continuing its investigation into Azenta, Inc. (AZTA) for potential violations of federal securities laws. This follows Azenta's announcement of missed Q2 2026 financial estimates, a $149 million goodwill impairment, and lowered 2026 outlook, which led to a significant drop in its stock price. Investors who lost money are encouraged to contact the law firm for a potential claim.
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
The Law Offices of Howard G. Smith are investigating Azenta, Inc. (AZTA) on behalf of investors who suffered losses due to potential violations of federal securities laws. This investigation follows Azenta's Q2 2026 financial results, where the company missed EPS and revenue estimates, reported a $149 million goodwill impairment, and significantly lowered its 2026 organic revenue and adjusted EBITDA margin outlook. These announcements led to a 25.3% drop in Azenta's stock price on May 6, 2026, causing injury to investors.
INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA
Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (AZTA) following the company's release of its second quarter fiscal 2026 financial results and a reduced full-year outlook. Azenta's stock price fell significantly after it disclosed that its results fell short of expectations, impacted by execution gaps, a cautious demand environment, and a substantial goodwill impairment charge. The law firm encourages affected investors to contact them regarding a potential class action lawsuit.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Azenta, Inc. (AZTA) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has announced an investigation into Azenta, Inc. (AZTA) on behalf of investors following the company's Q2 2026 financial results. Azenta missed consensus estimates for EPS and revenue, reported a significant goodwill impairment, and reduced its 2026 outlook, leading to a 25.3% drop in stock price. The firm is encouraging investors affected by these developments to learn more about the investigation.
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
Azenta, Inc. (Nasdaq: AZTA) has released its annual Environmental, Social, & Governance (ESG) report for the fiscal year ending September 30, 2025, detailing progress across environmental protection, social impact, and responsible operations. Key achievements include the first-time disclosure of Scope 3 GHG emissions, submission of near-term GHG reduction targets to SBTi, and a 40% reduction in Scope 1 and 2 carbon footprint. The company also highlighted sustainable innovations and initiatives supporting employee well-being and operational excellence.
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
Azenta, Inc. announced the publication of its annual Environmental, Social, & Governance (ESG) report for the fiscal year ended September 30, 2025. The report details progress across environmental protection, social impact, and responsible operations, including first-time disclosure of Scope 3 GHG emissions, submission of near-term GHG reduction targets, and a significant reduction in Scope 1 and 2 carbon footprint. The company also highlighted advancements in sustainable innovation and employee well-being initiatives.
Azenta, Inc. (AZTA) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
The Law Offices of Howard G. Smith are investigating Azenta, Inc. (AZTA) on behalf of investors who suffered losses due to potential violations of federal securities laws. This investigation follows Azenta's Q2 2026 financial results, which missed consensus estimates, reported a $149 million goodwill impairment, and led to a significant drop in its stock price. The firm is encouraging affected shareholders to contact them to discuss potential claims for recovery.
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
Azenta has published its 2025 Environmental, Social, and Governance (ESG) Report. This report highlights the company's commitment and progress across various ESG initiatives.
INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA
Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of its investors. This investigation follows Azenta's announcement of disappointing Q2 fiscal 2026 financial results, including execution gaps, a cautious demand environment, and a $149 million goodwill impairment charge. The company also reduced its full-year fiscal 2026 outlook, leading to a significant 25.31% drop in its stock price on May 6, 2026.
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
Azenta (NASDAQ: AZTA) has published its 2025 ESG report, detailing significant progress in environmental protection, social impact, and responsible operations. Key highlights include the first-time disclosure of Scope 3 GHG emissions, a target for 45% absolute reduction in Scope 1 and 2 emissions by FY2033, and sourcing 72% of its electricity from renewable sources. The report also notes a 40% reduction in Scope 1 and 2 carbon footprint compared to FY2022, expanded sustainable products, and enhanced employee well-being programs.
Why is Azenta (AZTA) Trading So Low Despite Strong Balance Sheet
Azenta (AZTA) is trading near its 52-week low despite a strong balance sheet, including a low Price-to-Book ratio and a significant net cash position. The company is undergoing a strategic transformation to a pure-play life sciences entity, which has led to mixed financial performance and investor uncertainty. While analysts have a "Strong Buy" consensus with a high price target, execution risks, macroeconomic headwinds, and integration challenges are contributing to the current skeptical valuation.
Levi & Korsinsky Announces Investigation of Securities Claims Against Azenta, Inc. (AZTA)
Levi & Korsinsky, LLP has announced an investigation into securities claims against Azenta, Inc. (AZTA) following significant losses incurred by investors. This investigation comes after Azenta disclosed a $149 million goodwill impairment and slashed its full-year guidance in May 2026, just three months after reaffirming strong organic revenue growth and margin expansion targets to investors. Shareholders who suffered losses are encouraged to contact Levi & Korsinsky to discuss potential legal rights.
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
Azenta, Inc. announced the publication of its 2025 Environmental, Social, and Governance (ESG) report, highlighting progress in environmental protection, social impact, and responsible operations. Key achievements include disclosing Scope 3 GHG emissions for the first time, submitting near-term GHG reduction targets to SBTi, and reducing Scope 1 and 2 carbon footprint by approximately 40% compared to FY2022. The report details the company's commitment to sustainability and outlines future goals.
AZTA Investor Alert: Levi & Korsinsky Investigates Azenta, Inc. (AZTA) for Potential Securities Fraud
Levi & Korsinsky, LLP is investigating Azenta, Inc. (AZTA) for potential securities fraud following the company's Q2 FY 2026 results. Azenta reported a $160.8 million net loss and a $149 million goodwill impairment charge, significantly contradicting earlier guidance that had been reaffirmed just three months prior. Investors who suffered losses after purchasing AZTA shares are encouraged to contact Levi & Korsinsky to discuss their legal rights.
AZTA Investor Alert: Levi & Korsinsky Investigates Azenta, Inc. (AZTA) for Potential Securities Fraud
Levi & Korsinsky is investigating Azenta, Inc. (AZTA) for potential securities fraud following the company's Q2 FY 2026 results. Azenta reported a significant net loss of $160.8 million, including a $149 million goodwill impairment, leading to a cut in its full-year guidance that had been reaffirmed just three months prior. Shareholders who suffered losses are encouraged to contact the law firm to discuss their legal rights.
AZTA Investors Have Opportunity to Join Azenta, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm is investigating potential securities law violations by Azenta, Inc. (AZTA) on behalf of investors. The investigation follows Azenta's Q2 2026 financial results, which missed analyst estimates due to "execution-related shortfalls" and a "cautious prolonged demand environment," leading to a 25.3% stock drop. Shareholders who suffered losses are encouraged to contact the law firm to discuss their rights.
